Biologicals and small molecules for cancer

Pharmapark is a full-cycle biotechnological company with over 20 years of experience in the development, production, and sales of biomedical drugs. The company specializes in creating high-quality medications through advanced biotechnology, focusing on both generic and original medicines. Their commitment to research and development is evident in their rigorous testing processes, which ensure the efficacy and safety of their products. Pharmapark's developments are protected by international and Russian patents, reinforcing their position as a trusted leader in the biopharmaceutical industry. The company aims to provide effective treatments for a wide range of health conditions, including various cancers and chronic diseases, thereby enhancing healthcare accessibility across Russia.

Pharmapark's operational capabilities include a state-of-the-art production facility equipped with two hardware-technological lines for the creation of genetically engineered therapeutic proteins, cytokines, and monoclonal antibodies. Their research and development center is dedicated to all stages of pharmaceutical development, from initial research to the scaling and validation of production processes. The company collaborates with leading global institutions and partners to localize and register medical drugs, ensuring that they can meet the healthcare needs of patients effectively. Through their comprehensive services, Pharmapark is committed to advancing medical science and improving the quality of life for individuals facing debilitating diseases.

Russia

Pharmapark Global Limited is a pharmaceutical company that operates in Russia and other CIS countries. It partners with other biopharmaceutical companies to market and develop drugs. Pharmapark Siegfried is a part of the company and is located in northwest Switzerland. It is involved in the life science cluster and is in close proximity to other pharmaceutical companies. Pharmapark LLC is also active in drug pipelines, patents, and clinical trials. The company has over 201-500 employees and is privately held.

Pharmapark

Company Details